| Dr Emily A Mitchell, DO | |
|
303 S Nappanee St, Elkhart, IN 46514-2066 | |
| (574) 296-3200 | |
| (574) 296-3392 |
| Full Name | Dr Emily A Mitchell |
|---|---|
| Gender | Female |
| Speciality | General Surgery |
| Experience | 14 Years |
| Location | 303 S Nappanee St, Elkhart, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043537020 | NPI | - | NPPES |
| PENDING | Medicaid | IN | |
| PENDING | Other | IN | RAILROAD MEDICARE PIN |
| 1043537020 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 5101018742 (Michigan) | Secondary |
| 208600000X | Surgery | 02004694A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension Borgess Lee Hospital | Dowagiac, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ascension Medical Group Promed | 7315856077 | 233 |
| Three Rivers Health System Inc | 8729245584 | 40 |
News Archive
The NIH has granted a University of Texas at Dallas researcher and a university-affiliated biomedical firm $1.7 million to investigate whether nerve stimulation offers a long-term cure for tinnitus.
Amgen today announced positive results from several new analyses of two Phase 3 trials studying denosumab compared with Zometa® (zoledronic acid), the current standard of care, for the treatment of bone metastases in patients with advanced breast cancer ("136 study") and solid tumors or multiple myeloma ("244 study"). Results from these trials reinforce denosumab's consistent ability to delay the complications of bone metastases in patients with advanced cancer. These results are being presented during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago.
After its release in 2017, the Netflix series "13 Reasons Why" spurred controversy over concerns that its portrayal of a teenage girl's suicide could increase suicide contagion among adolescents.
Funded by a grant from the U.S. Environmental Protection Agency (EPA), the Bill Blackwood Law Enforcement Management Institute of Texas (LEMIT) launched a free, online training program to strengthen civil and criminal environmental and public health enforcement efforts at the local, county, state, and tribal levels.
› Verified 5 days ago
| Entity Name | Ascension Medical Group Promed |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497709869 PECOS PAC ID: 7315856077 Enrollment ID: O20031216000478 |
News Archive
The NIH has granted a University of Texas at Dallas researcher and a university-affiliated biomedical firm $1.7 million to investigate whether nerve stimulation offers a long-term cure for tinnitus.
Amgen today announced positive results from several new analyses of two Phase 3 trials studying denosumab compared with Zometa® (zoledronic acid), the current standard of care, for the treatment of bone metastases in patients with advanced breast cancer ("136 study") and solid tumors or multiple myeloma ("244 study"). Results from these trials reinforce denosumab's consistent ability to delay the complications of bone metastases in patients with advanced cancer. These results are being presented during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago.
After its release in 2017, the Netflix series "13 Reasons Why" spurred controversy over concerns that its portrayal of a teenage girl's suicide could increase suicide contagion among adolescents.
Funded by a grant from the U.S. Environmental Protection Agency (EPA), the Bill Blackwood Law Enforcement Management Institute of Texas (LEMIT) launched a free, online training program to strengthen civil and criminal environmental and public health enforcement efforts at the local, county, state, and tribal levels.
› Verified 5 days ago
| Entity Name | Elkhart Clinic, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013912286 PECOS PAC ID: 2365341674 Enrollment ID: O20090116000467 |
News Archive
The NIH has granted a University of Texas at Dallas researcher and a university-affiliated biomedical firm $1.7 million to investigate whether nerve stimulation offers a long-term cure for tinnitus.
Amgen today announced positive results from several new analyses of two Phase 3 trials studying denosumab compared with Zometa® (zoledronic acid), the current standard of care, for the treatment of bone metastases in patients with advanced breast cancer ("136 study") and solid tumors or multiple myeloma ("244 study"). Results from these trials reinforce denosumab's consistent ability to delay the complications of bone metastases in patients with advanced cancer. These results are being presented during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago.
After its release in 2017, the Netflix series "13 Reasons Why" spurred controversy over concerns that its portrayal of a teenage girl's suicide could increase suicide contagion among adolescents.
Funded by a grant from the U.S. Environmental Protection Agency (EPA), the Bill Blackwood Law Enforcement Management Institute of Texas (LEMIT) launched a free, online training program to strengthen civil and criminal environmental and public health enforcement efforts at the local, county, state, and tribal levels.
› Verified 5 days ago
| Entity Name | Lakeland Medical Practices |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538397120 PECOS PAC ID: 1658427042 Enrollment ID: O20090928000216 |
News Archive
The NIH has granted a University of Texas at Dallas researcher and a university-affiliated biomedical firm $1.7 million to investigate whether nerve stimulation offers a long-term cure for tinnitus.
Amgen today announced positive results from several new analyses of two Phase 3 trials studying denosumab compared with Zometa® (zoledronic acid), the current standard of care, for the treatment of bone metastases in patients with advanced breast cancer ("136 study") and solid tumors or multiple myeloma ("244 study"). Results from these trials reinforce denosumab's consistent ability to delay the complications of bone metastases in patients with advanced cancer. These results are being presented during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago.
After its release in 2017, the Netflix series "13 Reasons Why" spurred controversy over concerns that its portrayal of a teenage girl's suicide could increase suicide contagion among adolescents.
Funded by a grant from the U.S. Environmental Protection Agency (EPA), the Bill Blackwood Law Enforcement Management Institute of Texas (LEMIT) launched a free, online training program to strengthen civil and criminal environmental and public health enforcement efforts at the local, county, state, and tribal levels.
› Verified 5 days ago
| Entity Name | Three Rivers Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720350903 PECOS PAC ID: 8729245584 Enrollment ID: O20140729001948 |
News Archive
The NIH has granted a University of Texas at Dallas researcher and a university-affiliated biomedical firm $1.7 million to investigate whether nerve stimulation offers a long-term cure for tinnitus.
Amgen today announced positive results from several new analyses of two Phase 3 trials studying denosumab compared with Zometa® (zoledronic acid), the current standard of care, for the treatment of bone metastases in patients with advanced breast cancer ("136 study") and solid tumors or multiple myeloma ("244 study"). Results from these trials reinforce denosumab's consistent ability to delay the complications of bone metastases in patients with advanced cancer. These results are being presented during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago.
After its release in 2017, the Netflix series "13 Reasons Why" spurred controversy over concerns that its portrayal of a teenage girl's suicide could increase suicide contagion among adolescents.
Funded by a grant from the U.S. Environmental Protection Agency (EPA), the Bill Blackwood Law Enforcement Management Institute of Texas (LEMIT) launched a free, online training program to strengthen civil and criminal environmental and public health enforcement efforts at the local, county, state, and tribal levels.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Emily A Mitchell, DO Po Box 2968, Elkhart, IN 46515-2968 Ph: (574) 296-3200 | Dr Emily A Mitchell, DO 303 S Nappanee St, Elkhart, IN 46514-2066 Ph: (574) 296-3200 |
News Archive
The NIH has granted a University of Texas at Dallas researcher and a university-affiliated biomedical firm $1.7 million to investigate whether nerve stimulation offers a long-term cure for tinnitus.
Amgen today announced positive results from several new analyses of two Phase 3 trials studying denosumab compared with Zometa® (zoledronic acid), the current standard of care, for the treatment of bone metastases in patients with advanced breast cancer ("136 study") and solid tumors or multiple myeloma ("244 study"). Results from these trials reinforce denosumab's consistent ability to delay the complications of bone metastases in patients with advanced cancer. These results are being presented during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago.
After its release in 2017, the Netflix series "13 Reasons Why" spurred controversy over concerns that its portrayal of a teenage girl's suicide could increase suicide contagion among adolescents.
Funded by a grant from the U.S. Environmental Protection Agency (EPA), the Bill Blackwood Law Enforcement Management Institute of Texas (LEMIT) launched a free, online training program to strengthen civil and criminal environmental and public health enforcement efforts at the local, county, state, and tribal levels.
› Verified 5 days ago
Bradley Gordan, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 Arcade Ave Ste 320, Elkhart, IN 46514 Phone: 574-523-7900 Fax: 574-523-7909 | |
Luis Alfonso Benavente Chenhalls, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 Arcade Ave, Suite 340, Elkhart, IN 46514 Phone: 574-293-3317 Fax: 574-293-3523 | |
Nicholas Miller, Surgery Medicare: Medicare Enrolled Practice Location: 500 Arcade Ave Ste 210, Elkhart, IN 46514 Phone: 574-389-5656 Fax: 574-523-7891 | |
Anatoliy V. Rudin, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 Arcade Ave Ste 320, Elkhart, IN 46514 Phone: 574-293-3317 | |
Dr. Kelly R. Puster, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 303 S Nappanee St, Elkhart, IN 46514 Phone: 574-296-3220 Fax: 574-296-3322 | |
Dr. Jeffery A Mark, MD Surgery Medicare: Medicare Enrolled Practice Location: 515 S 2nd St, Elkhart, IN 46516 Phone: 574-295-4141 |